Program Monitoring
7,077
Number of Clinics
56,235
Number of Settlements
5,109,373
Enrollments
21,506,643
Disbursements
Bauchi
1,110
9,716
720,618
3,085,424
Gombe
519
5,234
329,208
1,397,724
Jigawa
786
7,576
917,451
4,213,212
Kaduna
276
2,205
210,570
806,411
Kano
1,264
11,757
1,001,314
3,990,007
Katsina
1,299
6,806
1,076,770
4,879,217
Kebbi
544
2,888
227,828
863,033
Niger
467
3,032
51,878
81,621
Sokoto
380
2,903
205,621
785,189
Yobe
160
1,809
46,794
82,367
Zamfara
272
2,309
321,321
1,322,438
Vaccination Rate
95.69%
Penta 1
91.22%
Penta 2
88.34%
Penta 3
85.82%
Measles
Bauchi
95.51%
91.4%
88.7%
85.72%
Gombe
96.3%
92.79%
90.23%
87.31%
Jigawa
95.83%
92.54%
90.47%
87.75%
Kaduna
95.68%
90.75%
87.28%
83.45%
Kano
95.04%
90.92%
88.16%
85.18%
Katsina
96.42%
92.87%
90.67%
88.46%
Kebbi
94.93%
88.45%
84.24%
82.02%
Niger
94.33%
84.35%
77.92%
82.64%
Sokoto
94.16%
83.88%
77.85%
74.09%
Yobe
96.07%
90.45%
85.93%
89.03%
Zamfara
96.4%
88.78%
83.84%
83.38%
Impact Evaluation Key Findings
An independent randomized controlled trial found, among other positive findings, that New Incentives’ All Babies program:
Increased Coverage
The program doubled the percentage of infants who were fully vaccinated, increasing coverage from roughly a quarter to just over half of all infants.
Improved Timeliness
Infants who received measles vaccines were 33 percentage points more likely to receive the vaccine within one month of the recommended age.
Improved Knowledge and Attitudes
Caregivers in areas served by the program had better knowledge and more favorable attitudes toward immunization.
Reduced Stockouts
Government clinics with the program were 18 percentage points less likely to report vaccine stockouts during the last 12 months.
Randomized Controlled Trial
Expected in Dec 2020
Study with two-arm cluster RCT
- Control (83 clinics): No intervention, status quo
- Treatment (84 clinics): New Incentives full program
- This design will measure the causal effect of New Incentives' program on the likelihood of an infant receiving a vaccine.
.svg)
.svg)
.png)